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Abstract: Leptospirosis is one of the most common zoonotic infections worldwide, including in most
livestock, some companion animals, horses, wildlife, and humans. Epidemiological estimation of
its prevalence in all species is difficult due to the variety of clinical presentations and challenges
regarding laboratory diagnosis. The purpose of this study was to measure the seroprevalence of
leptospiral infection in Arabian horses kept in the largest breeding farms in Poland, representing over
15% of the Polish Arabian horse population. Leptospira antibodies were detected by MAT (cut-off
1:100) in 33.2% of serum samples (204 of 615 animals) (CI 95%: 29.6–37.0%), most frequently reacting
with the serovar Grippotyphosa, similar to previous reports in populations of randomly selected
horses. These results indicated high Leptospira seropositivity, thus, although any form of clinical
leptospirosis is rare, it may be postulated that the leptospiral exposure is widespread.
Keywords: Leptospira; seroprevalence; horse; Arabians
1. Introduction
Leptospirosis is a ubiquitous infectious and somewhat contagious bacterial zoonotic
disease caused by the spirochete Leptospira involving many species and serovars. It affects
humans, domestic animals, wildlife and even reptiles, posing a worldwide problem for
both animal and public health. In horses, the clinical presentation of Leptospira infection
varies, making a definitive diagnosis often difficult. The majority of equine cases are
asymptomatic. Clinical signs are mostly related to the mare’s reproductive tract and
kidneys [1,2]. Additionally, Leptospira infection can contribute to the development of equine
recurrent uveitis (ERU), which appears to be the most important clinical outcome. Although
many etiologies are implicated with ERU globally, in continental Europe, infection with
Leptospira is considered the leading cause. In the US and UK, scientific data also indicate the
role of Leptospira, which has been isolated from ERU eyes, but the immune mediated process
has received more attention [3,4]. Serovars Pomona and Grippotyphosa predominate in
equine cases in the US and in Europe, respectively, regardless the clinical presentation.
Due to the fact that chronic intraocular leptospiral infection promotes ERU, any
positive serum titer may suggest an increased risk of ERU. The testing of intraocular
Pathogens 2021, 10, 688. https://doi.org/10.3390/pathogens10060688 https://www.mdpi.com/journal/pathogens
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fluids is the most valuable tool for confirming leptospiral origin of uveitis and also for
choosing the proper therapeutic protocol. Detection of pathogenic bacteria or anti-Leptospira
antibodies in the eye indicates that trans-pars-plana vitrectomy is a treatment of choice for
recurrences, whereas in other cases, vitrectomy is less effective in reducing the recurrence
rates and protecting the affected eye from further damage [2–10].
Serological methods are very useful for leptospirosis screening and sometimes diag-
nosis (regarding level of titers and/or acute-convalescent samples), however, their efficacy
depends on the stage of infection and the immune response of the host. A number of tech-
niques for the detection of antibodies against Leptospira serovars has been developed but
the microscopic agglutination test (MAT) with live antigens remains the only method ac-
knowledged by the World Organization for Animal Health [11] and is used as the reference
method also for screening.
Almost all epidemiological studies in horses are based on serology with various
panels of serovars as test antigens. The reported seroprevalence varied from 1% to over
80% depending on the geographic location, the serovars assessed and the differences in
titer cut-off across the studies [12–14].
In Poland, several studies on leptospirosis in domestic and wild animals have been
conducted [15,16], but the data regarding horses are quite limited. To date, reports on
the prevalence of Leptospira infections in equine species in Poland were published in 1965,
1997 and 2013 [17–19], and all of them tested different numbers of serovars and covered
populations of various breeds.
Arabians are especially important in Poland, as the Polish Arabian horse breeding
program is considered one of the largest and the most successful worldwide. In Polish
Arabian populations, ERU is the most common ocular disease, reaching the prevalence of
5.5%, often leading to poor vision and even blindness [20]. Thus, the purpose of this study
was to estimate the seroprevalence of Leptospira (six serovars) in Arabian horses in Poland.
2. Results
Among 615 examined samples, 204 were positive at the dilution of 1:100 or more,
showing 33.2% (confidence interval-CI 95%: 29.6–37.0%) seroprevalence of Leptospira
(Table 1). Antibodies reacting with the serogroup Grippotyphosa (MAT is serogroup-
specific assay) were found the most frequently (55.9% of positive horses) and the titers
ranged from 1:100 to 1:3200. The titers for other investigated serogroups ranged from 1:100
to 1:800 (Table 2). Titers ≥ 1:400 were identified in over 39% of MAT-positive sera reacting
with one serovar. There were no significant differences among farms (p = 0.78). However,
seroprevalence increased with age and differed significantly (p < 0.001) between young
horses under 4 years (33%) and the horses older than 5 years (50%). Thirty nine of 204
positive sera (19.1%) cross-reacted with two or more serovars (Table 1). In 18 cases (46.2%),
reactions with one serovar predominated: Grippotyphosa in 13 cases, Pomona in 2, Sejroe,
Tarrasovi and Canicola—one case each.





No. of Positive Horses
Seroprevalence (%)
Number of Positive Reactions in 1, 2, 3 and 4 Serotypes





A 270 82 (30.4%) 3 (3.7%) 50 (61.0%) 7 (8.5%) 5 (6.1%) 1 (1.2%) 3 (3.7%) 12 (14.6%) 1 (1.2%) 0 (0.0%)
B 292 109 (37.3%) 1 (0.9%) 60 (55.0%) 5 (4.6%) 5 (4.6%) 0 (0.0%) 15 (13.8%) 21 (19.1%) 1 (0.9%) 1 (0.9%)
C 53 13 (24.5%) 0 (0.0%) 4 (30.8%) 0 (0.0%) 5 (38.5%) 1 (7.7%) 0 (0.0%) 3 (23.1%) 0 (0.0%) 0 (0.0%)
Total 615 204 (33.2%) 4 (2.0%) 114 (55.9%) 12 (5.9%) 15 (7.4%) 2 (1.0%) 18 (8.8%) 36 (17.6%) 2 (1.0%) 1 (0.5%)
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Table 2. Distribution of titers among serum samples reacting in MAT with one serovar.
Serovar 1:100 1:200 1:400 1:800 1:1600 1:3200
Grippotyphosa 18.1% 25.9% 24.5% 17.5% 10.6% 3.4%
Pomona 44.5% 22.2% 11.1% 22.2%
Tarassovi 78.4% 13.0% 8.6%
Sejroe 45.5% 40.9% 13.6%
Canicola 36.8% 42.1% 21.1%
Icterohaemorrhagiae 53.8% 38.5% 7.7%
3. Discussion
The results of this study suggest a high exposure rate for Leptospira spp. in horses
in Poland. The seroprevalence in Arabians (33.2%) is generally consistent with previous
studies on mixed populations of healthy horses in northern Poland, indicating 20% [18]
and 39.0% [17]. However, a much earlier study indicated seroprevalence as low as approxi-
mately 11% in healthy horses but much higher (up to 75%) when related to leptospirosis
outbreaks on farms [19], which is consistent with studies from other countries [21–23].
There is no standard protocol for the estimation of Leptospira seroprevalence. Detection
of antibodies directed against leptospires widely varies among investigations because of
different MAT titer values considered as “positive” and different antigens used. This study
utilized six live antigens for MAT. In the previous reports from Poland, panels of 17, 13
and 8 serovars were analyzed. It is noteworthy that the seroprevalence determined in this
study (33.2%) using 6 antigens was higher than in surveys with 8 and 13 antigens (20% and
11%, respectively) and close to the one with 17 antigens (39.0%) [17–19].
According to the OIE Terrestrial Manual, titer of 1:100 is interpreted as positive for
international trade, but many laboratories do not consider titer to be positive until 1:200 [14]
or 1:400 [13]. Sometimes, according to local regulations, other cutoffs are used. For example
in Croatia a titer of >400 is considered positive with exception of serovars Bratislava and
Australis, when >200 is a positive cutoff [24], while in the latest study from New Zealand
the end point titer was recorded at the highest dilution where at least 50% agglutination
occurred and it mostly was 1:25 or 1:50 [23]. In this study, the cutoff 1:100 was used to make
the data consistent with OIE manual recommendations and to make them comparable with
the last study from Poland [17].
It is generally considered that Leptospira seroprevalence is lower in temperate climate
countries [25] and a seropositivity of 30–45% is expected for tropical regions [14,21]. How-
ever, recent data clearly indicate that high seroprevalence is not limited to tropical regions
only. Data from Poland previously reported by Arent et al. [17] and confirmed in this
study were as high [26] as reported in horses in tropical regions. Additionally, very high
seropositivity has been reported in Switzerland and Colorado in the US, where almost 60%
and 82% respectively of clinically healthy horses were positive for one or more Leptospira
antigens [22,27]. On the other hand, in Israel, seroprevalence was low and only individuals
out of hundreds investigated horses were seropositive [28]. The risk of Leptospira infection
may be related to the rainfall during the studies, rodent population increases or decreases
or other, sometimes not recognized factors that have to be taken into consideration to
interpret and compare reported data properly. This explanation deals also with the differ-
ences in seroprevalence of Leptospira serogroups in horses among studies from the same
country [1,2]. It should be mentioned that the MAT has limitations in the diagnosis of
chronic infection in individual animals and in the diagnosis of endemic infections in herds.
Infected animals may abort or be renal/genital carriers with MAT titers below the widely
accepted minimum significant titer of 1:100 (final dilution) [11].
The Grippotyphosa serogroup has historically been the predominate serovar among
horses in central Europe [14]. The results obtained in this study indicate that antibodies
against this serogroup were detected in most seropositive horses (55.9%), so agree with
previous studies, including the ones conducted in Poland. Zwierz et al. [19] reported in
1965 that the serovar Grippotyphosa was responsible for 30–90% of Leptospira infections in
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horses in Poland. In further studies approximately 10–40% samples were also positive for
the this serovar [17,18].
The study from Croatia conducted in 2009–2014 revealed seroprevalence of Leptospira
spp. from 6.2% to 23.4% (average 13.47%) with the most frequently isolated serogroups
being Australis, Pomona and Grippotyphosa [29]. In the earlier Croatian study, 37.2% of
horses were positive and the highest seroprevalences were found for serogroups Bratislava,
Pomona and Icterohaemorrhagiae [24]. In contrast, the seroprevalence of Leptospira spp.
among horses in neighboring Serbia was estimated at only 6.3% [30] and the most prevalent
serogroups were Grippotyphosa and Icterohaemorrhagiae.
The seroprevalence in Italy varied from 1.5% [13], through 11.4% [31] to 67.2% [32]
and reactions against serovars Bratislava, Canicola, Tarassovi, Copenhageni and Pomona
were detected the most frequently, while rarely for Grippotyphosa.
The serological survey carried out in Sweden estimated the prevalence of serovar
Grippotyphosa at 0.4% only [25] while serovars Bratislava (16.6%) and Icterohaemorrhagiae
(8.3%) were the most prevalent. In Switzerland, serogroups Pyrogenes, Canicola and
Australis were the most common among horses [27].
This study covered the representative population involving about 15% of Polish
Arabian horses, adding significant data to the epidemiological knowledge base regarding
Leptospira titers in horses in Poland and Central Europe. The seroprevalence measured in
this study was high while clinical evidence of active Leptospira infections was not found.
Titers confirmed that the exposure is high and does not manifest clinically.
The limitation of this study was the lack of MAT testing against Bratislava serovar.
Bratislava is the host adapted serovar found across the globe in horses with the highest
seroprevalence. However, it has been shown that at least some of the strains and serovars
may not to be pathogenic nor host adapted for horses [33]. It is likely that the use of
Bratislava as the antigen would have resulted in even higher seroprevalence than reported
here. It also cannot be excluded, that high titers among some of the serum samples
reacting in MAT with Grippotyphosa and Canicola serovars may reflect cross-reacting with
antibodies against Bratislava.
4. Materials and Methods
4.1. Selected Population of Arabians
The Polish Arabian Stud Book estimates the entire population of this breed at roughly
4000 animals. Most breeding mares and stallions reside on 3 main Arabian stud farms, all of
which are covered in this study. The study population included 425 mares and 190 stallions,
a total of 615 horses aged from 6 months to 33 years, representing over 15% of Arabians
residing in Poland. Serum samples were collected over 2011–2013 and stored at −20◦ C
until the Leptospira titer was tested. Clinical history for the five years prior to sampling was
analyzed for each horse [1,2], so clinical records from the years 2006–2013 were checked
and revealed no clinical signs suggesting leptospirosis. Samples were taken in the summer
season, during routine veterinary procedures, so according to Polish regulations did not
require the permission of the Local Ethics Committee.
4.2. Analyses
All sera were tested using the microscopic agglutination test (MAT) (World Organiza-
tion of Animal Health-OIE, 2019) [11] for six Leptospira serovars as follows: Icterohaem-
orrhagiae, Pomona and Canicola belonging to Leptospira interrogans, Sejroe and Tarassovi
belonging to L. borgpetersenii and Grippotyphosa belonging to L. kirschneri. The initial
dilution of sera was 1:100, according to the OIE Terrestrial Manual. Sera reacting positively
with one or more serovars in the preliminary examination were additionally tested by the
twofold dilution series titered to the endpoint defined as dilution of serum that shows 50%
agglutination. Farm-level seroprevalences were compared using a chi-square test, p < 0.05
was presumed significant.
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5. Conclusions
It may be postulated that the exposure rate of Leptospira spp. in Poland has become
higher due to climate change and breeding conditions or increased populations of carriers
shedding Leptospira. Further, many horses might have been only exposed to this infectious
agent, and so only seroconverted without any clinical outcome. Therefore, the occurrence
and duration of infections without clinical signs will remain unknown. However, the
active onset of infections cannot be excluded and clinical outcomes such as abortion, renal
pathology, and septicemia may occur. Thus, the owners, farm managers and the attending
veterinarians should be aware of the potential threat of Leptospira infection in Arabian
horses as a potential zoonotic disease. Leptospira infection should be considered as one of
the potential pathogens in the diagnostic panels.
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